<DOC>
	<DOC>NCT00920270</DOC>
	<brief_summary>Nebulized Colistin for Adjunctive Therapy of Hospital-Acquired Pneumonia caused by Gram Negative Bacteria should be more effective than conventional therapy</brief_summary>
	<brief_title>Nebulized Colistin for Hospital-Acquired Pneumonia</brief_title>
	<detailed_description>Randomized Controlled Clinical Trial in hospitalized adult patients with hospital-acquired pneumonia. The patients are allocated to conventional group or nebulized colistin group. The conventional group receives conventional antibiotics whereas the nebulized colistin group receives nebulized colistin in addition to conventional antibiotics. The outcomes are clinical response and microbiological responses.</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<criteria>Adult (age&gt;18 years) hospitalized patient with hospitalacquired pneumonia due to Gram negative bacteria pregnancy lactating woman colistin allergy severe renal impairment epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Hospital-Acquired Pneumonia</keyword>
	<keyword>Gram Negative Bacteria</keyword>
</DOC>